254 related articles for article (PubMed ID: 37340443)
1. METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.
Wei W; Zhang ZY; Shi B; Cai Y; Zhang HS; Sun CL; Fei YF; Zhong W; Zhang S; Wang C; He B; Jiang GM; Wang H
J Exp Clin Cancer Res; 2023 Jun; 42(1):151. PubMed ID: 37340443
[TBL] [Abstract][Full Text] [Related]
2. METTL16-mediated N6-methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer.
Li J; Yang F; Wang Z; Zheng S; Zhang S; Wang C; He B; Wang JB; Wang H
Cell Prolif; 2024 May; 57(5):e13590. PubMed ID: 38084791
[TBL] [Abstract][Full Text] [Related]
3. m
Wang A; Sun Y; Wang X; Yan Z; Wang D; Zeng L; Lu Q
Aging (Albany NY); 2023 Aug; 15(16):8444-8457. PubMed ID: 37647025
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.
Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M
J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750
[TBL] [Abstract][Full Text] [Related]
5. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
6. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
7. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression.
Liu N; Zhang J; Chen W; Ma W; Wu T
J Exp Clin Cancer Res; 2023 Oct; 42(1):263. PubMed ID: 37817227
[TBL] [Abstract][Full Text] [Related]
8. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
9. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
10. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
Dai X; Chen K; Xie Y
Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
[TBL] [Abstract][Full Text] [Related]
11. METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m
Cheng J; Xu Z; Tan W; He J; Pan B; Zhang Y; Deng Y
J Cell Physiol; 2024 Mar; 239(3):e31068. PubMed ID: 37357526
[TBL] [Abstract][Full Text] [Related]
12. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.
Wang XK; Zhang YW; Wang CM; Li B; Zhang TZ; Zhou WJ; Cheng LJ; Huo MY; Zhang CH; He YL
J Cell Mol Med; 2021 Jul; 25(14):6602-6617. PubMed ID: 34075693
[TBL] [Abstract][Full Text] [Related]
13. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m
Dai YZ; Liu YD; Li J; Chen MT; Huang M; Wang F; Yang QS; Yuan JH; Sun SH
Cell Mol Biol Lett; 2022 May; 27(1):41. PubMed ID: 35596159
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Wang Y; Lu JH; Wu QN; Jin Y; Wang DS; Chen YX; Liu J; Luo XJ; Meng Q; Pu HY; Wang YN; Hu PS; Liu ZX; Zeng ZL; Zhao Q; Deng R; Zhu XF; Ju HQ; Xu RH
Mol Cancer; 2019 Dec; 18(1):174. PubMed ID: 31791342
[TBL] [Abstract][Full Text] [Related]
15. The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment.
Zhang Z; Xie Z; Lin J; Sun Z; Li Z; Yu W; Zeng Y; Ye G; Li J; Ye F; Su Z; Che Y; Xu P; Zeng C; Wang P; Wu Y; Shen H
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795489
[TBL] [Abstract][Full Text] [Related]
16. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
17. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract][Full Text] [Related]
18. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
19. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
[TBL] [Abstract][Full Text] [Related]
20. METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.
Xue M; Dong L; Zhang H; Li Y; Qiu K; Zhao Z; Gao M; Han L; Chan AKN; Li W; Leung K; Wang K; Pokharel SP; Qing Y; Liu W; Wang X; Ren L; Bi H; Yang L; Shen C; Chen Z; Melstrom L; Li H; Timchenko N; Deng X; Huang W; Rosen ST; Tian J; Xu L; Diao J; Chen CW; Chen J; Shen B; Chen H; Su R
J Hematol Oncol; 2024 Feb; 17(1):7. PubMed ID: 38302992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
